Looking forward to James presenting the shareholder update today at 1pm
In this session, I will discuss:
- What to expect from our Phase 2a trial, with First Patient In and Dosed (FPID) anticipated in the coming weeks.
- How our promising Phase 1b results could help turn our Phase 2 trial into a registrational study.
- The significance of the Fast Track Designation granted by the FDA in April, and what it means for our potential accelerated path to commercialisation.
- Forums
- ASX - By Stock
- Prescient Therapeutics Shareholder Update
PTX
prescient therapeutics limited
Add to My Watchlist
9.76%
!
4.5¢

Looking forward to James presenting the shareholder update today...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.5¢ |
Change
0.004(9.76%) |
Mkt cap ! $43.96M |
Open | High | Low | Value | Volume |
4.2¢ | 4.6¢ | 4.2¢ | $170.8K | 3.901M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 200345 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 229105 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 200345 | 0.044 |
2 | 70000 | 0.043 |
2 | 907586 | 0.042 |
5 | 531097 | 0.041 |
22 | 1364748 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 229105 | 4 |
0.046 | 489270 | 3 |
0.047 | 123151 | 2 |
0.048 | 314234 | 5 |
0.049 | 844594 | 6 |
Last trade - 15.14pm 11/08/2025 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online